雅虎香港 搜尋

搜尋結果

1. 其他人也問了

   Is prostate cancer curable?

   • Prostate cancer is the most common type of cancer experienced by men. It's also very curable. Thanks to new advances in science and treatments, more men are surviving prostate cancer than ever before.

   Prostate Cancer - UChicago Medicine

   www.uchicagomedicine.org/cancer/types-treatments/prostate-cancer

   查看此問題的所有搜尋結果

   Do you need treatment for prostate cancer?

   • Many others are safely followed without needing treatment. The world-renowned prostate cancer team at the University of Chicago Medicine is highly skilled in the most up-to-date, technologically advanced methods for the diagnosis and treatment of prostate cancer.

   Prostate Cancer - UChicago Medicine

   www.uchicagomedicine.org/cancer/types-treatments/prostate-cancer

   查看此問題的所有搜尋結果

   What services does a Prostate Cancer Clinic offer?

   • Services include comprehensive genetic evaluations and screening plans for men with an increased prostate cancer risk due to genetic or hereditary factors. The clinic also offers novel treatment methods and access to clinical trials for men diagnosed with aggressive forms of prostate cancer.

   Prostate Cancer - UChicago Medicine

   www.uchicagomedicine.org/cancer/types-treatments/prostate-cancer

   查看此問題的所有搜尋結果

   What's new in immunotherapy for prostate cancer?

   • What’s new in immunotherapy for prostate cancer? One of the earliest immunotherapies approved by the Food and Drug Administration (FDA) for the treatment of cancer was a vaccine called sipuleucel-T. It’s been used to treat metastatic prostate cancer since 2010.

   What’s new in immunotherapy for prostate cancer?

   www.mdanderson.org/cancerwise/what-s-new-in-immunotherapy-for-prostate-cancer-treatment.h00-159697545.html

   查看此問題的所有搜尋結果

2. ascopubs.org › doi › 10Advancing Prostate Cancer Care: Treatment Approaches to ...

   ascopubs.org › doi › 10

   2024年5月23日 · Introduction. Genetics, genomics, and biomarker applications have become a critical component of prostate cancer (PCa) care. Applications of germline genetic testing, tumor genomics, and other biomarkers are now routinely used in risk assessment, determination of treatment course, prognosis, and monitoring.

3. www.uchicagomedicine.org › cancer › types-treatmentsProstate Cancer - UChicago Medicine

   www.uchicagomedicine.org › cancer › types-treatments

   • 網頁紀錄

   3 天前 · UChicago Medicine prostate cancer experts answer questions about the latest prostate cancer treatments, hereditary factors that increase the risk for prostate cancer and advanced research under way to improve the diagnosis and treatment of prostate cancer.

4. 焦點新聞

   • 

     New Prostate Cancer Treatment Options You Should Know About, From a Urologic Surgeon

     The American Cancer Society projects that in 2024, the United States will see approximately 299,010 new cases of prostate cancer and about 35,250 fatalities from the disease. Given that prostate cancer ranks as the second leading cause of cancer-related deaths among American men,

     The Healthy on MSN.com

     10 小時前

   • 

     Yahoo News Canada

     Study supports watch-and-wait approach to slow-growing prostate cancer

     1 小時前

   • 

     healthday

     Study Confirms Effectiveness of 'Watch-and-Wait' Approach to Prostate Cancer

     5 小時前

   • 

     english.vtv

     Targeted therapy is transforming breast and prostate cancer treatment

     2024年05月29日 07:00

   • Medpage Today on MSN.com

     More Evidence Backs Active Surveillance for Low-Risk Prostate Cancer

     16 小時前

   查看全部

5. www.mdanderson.org › cancerwise › what-s-new-in-immunotherapyWhat’s new in immunotherapy for prostate cancer?

   www.mdanderson.org › cancerwise › what-s-new-in-immunotherapy

   • 網頁紀錄

   2024年5月10日 · One of the earliest immunotherapies approved by the Food and Drug Administration (FDA) for the treatment of cancer was a vaccine called sipuleucel-T. It’s been used to treat metastatic prostate cancer since 2010. Since then, the introduction of immune checkpoint inhibitors has revolutionized the field of cancer treatment.

6. www.medscape.org › viewarticle › 943853Treatment Across the Prostate Cancer Continuum: Current ...

   www.medscape.org › viewarticle › 943853

   • 網頁紀錄

   3 天前 · Treatment Across the Prostate Cancer Continuum: Current Practice and Future Directions. 0.75 CME. Treatment Across the Prostate Cancer Continuum: Current Practice and Future Directions. Experts in the treatment of prostate cancer discuss current practices for nmCRPC and mHSPC. Authors: Karim Fizazi, MD, PhD; Celestia Higano, MD; Akash Patnaik, MD.

7. www.medscape.com › viewarticle › 1000620AUA 2024: Prostate Cancer Treatment and Testing Updates - ...

   www.medscape.com › viewarticle › 1000620

   2024年5月23日 · Mohammad M. Mahmoud, MD, MS, reflects on AUA 2024, noting the importance of genetic testing for patients with advanced prostate cancer, particularly those with de novo metastases, and...

8. www.onclive.com › clinical › prostate-cancerProstate Cancer | Clinical Oncology News | OncLive

   www.onclive.com › clinical › prostate-cancer

   • 網頁紀錄

   The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic,...

9. www.nature.com › pcan › research-articlesResearch articles | Prostate Cancer and Prostatic Diseases - ...

   www.nature.com › pcan › research-articles

   2024年5月7日 · Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation...